Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Placebo- och noceboeffekt
Engelsk titel: Placebo/nocebo Läs online Författare: Jacobsen, Nils ; Hensten, Arne Språk: Swe Antal referenser: 29 Dokumenttyp: Artikel UI-nummer: 15023314

Tidskrift

Tandläkartidningen 2015;107(2)50-6 ISSN 0039-6982 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Placebo, originally defined as an inactive medication giving a positive effect, compared to nocebo, which gives the converse result. Both situations are based on expectations of a positive or negative kind. Experimental data from pain research indicates that placebo responses are caused by stimulation of endogenous opioids and release of endogenous dopamine inhibiting receptors for pain and discomfort in the central nervous system and elicits wellbeing. Contrary, nocebo may lead to deactivation of the opioid/dopamine mechanisms and may increase the pain perception by way of the nerve transmitter substance, cholecystokinin. Simulataneously, anxiety and negative expectations may cause nocebo-related increased activity of stress related hormones, which affect the endocrine and immune systems. The placebo response is now considered as a parttaking factor in traditional medical treatment and has been proposed as an explanation for positive effects experienced by patients taking alternative medicine. Nocebo responses may follow events, such as media discussions on allegedly toxic environmental factors. In the dental clinic, placebo effects have been reported in cases of myofascial pain syndrome treatment, whereas nocebo responses may be responsible for the notion of being poisoned by mercury from dental amalgam or fearing dental treatment after earlier traumatizing experiences in the dental clinic. It is generally accepted that the quality of patient communication, rituals and treatment surroundings are of importance to the placebo/nocebo response.